Early changes in macular optical coherence tomography parameters after Ranibizumab intravitreal injection in patients with exsudative age-related macular degeneration

Table 2 The changes in BCVA/LogMAR measurements

	Time after injection	Mean ± SD	IC95%	P value
1	Baseline (prior injection—T0)	0.81 ± 0.16	0.74; 0.88	–
2	1 day after (T1)	0.76 ± 0.19	0.67; 0.85	0.066^a
3	7 days after (T7)	0.72 ± 0.23	0.61; 0.83	0.016^b
3	7 days after (T7)	0.72 ± 0.23	0.61; 0.83	0.157^c
4	30 days after (T30)	0.67 ± 0.24	0.55; 0.78	0.005^d
				0.028^e
				0.109^f

ISSN: 2056-9920